4//SEC Filing
Bodenstedt Matthias 4
Accession 0001213900-26-002907
CIK 0001821586other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:01 PM ET
Size
4.9 KB
Accession
0001213900-26-002907
Insider Transaction Report
Form 4
Bodenstedt Matthias
Chief Financial Officer
Transactions
- Award
Class A ordinary shares, par value $0.0001 per share
2026-01-07+354,296→ 1,276,305 total
Footnotes (1)
- [F1]Represents shares of restricted stock that vest in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920545
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:01 PM ET
- Size
- 4.9 KB